found in VABS (increase of the score) (p < 0.0001, ITT, RMANOVA), with statistically significant increases at 3 and 6 months (p < 0.0001). A large inter-patient variability in the incorporation of DSP into erythrocytes was observed, Chessa et al. Orphanet Journal of Rare Diseases 2014, 9:
Dexamethasone administered by autologous red blood cells (RBCs) is used in clinical trials and as co...
Erythrocyte-based drug delivery systems are emerging as potential new solutions for the release of d...
Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by alterations of the A-T ...
Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early onset ataxia,...
Background: Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early o...
BACKGROUND: Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early ...
Ataxia-telangiectasia (AT) is a rare, devastating neurodegenerative disease presenting with early-on...
A recent clinical observation reported on a dramatic improvement of neurological symptoms following ...
A recent clinical observation reported on a dramatic improvement of neurological symptoms following ...
Ataxia telangiectasia (A-T) is a rare incurable neurodegenerative disease caused by biallelic mutati...
Dexamethasone administered by autologous red blood cells (RBCs) is used in clinical trials and as co...
Erythrocyte-based drug delivery systems are emerging as potential new solutions for the release of d...
Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by alterations of the A-T ...
Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early onset ataxia,...
Background: Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early o...
BACKGROUND: Ataxia Teleangiectasia [AT] is a rare neurodegenerative disease characterized by early ...
Ataxia-telangiectasia (AT) is a rare, devastating neurodegenerative disease presenting with early-on...
A recent clinical observation reported on a dramatic improvement of neurological symptoms following ...
A recent clinical observation reported on a dramatic improvement of neurological symptoms following ...
Ataxia telangiectasia (A-T) is a rare incurable neurodegenerative disease caused by biallelic mutati...
Dexamethasone administered by autologous red blood cells (RBCs) is used in clinical trials and as co...
Erythrocyte-based drug delivery systems are emerging as potential new solutions for the release of d...
Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by alterations of the A-T ...